Collecting breast cancer tissue to predict recurrence risk
Part of Cancer, Skin clinical trials.
This study builds a “genome atlas” to better predict the chance that breast cancer will come back. It asks participants to share medical information and provide blood and tumor tissue samples, including samples kept in paraffin.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over 20 years old when you sign consent.
- You have a breast tumor that is either unconfirmed or confirmed as invasive breast cancer.
- Imaging shows the tumor is at least 1 centimeter in size.
- You can provide required samples: blood, fresh tumor tissue (if available), and paraffin tissue sections.
- You can follow study visits/procedures and sign informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial checks whether specific “surveillance” markers (measured from blood and bone marrow) can help predict if breast cancer comes back after standard treatments. It may help doctors monitor you more accurately and earlier if recurrence risk is high.
This study collects and stores tissue and fluid samples from people with a breast lump or breast cancer so researchers can study cancer biology in the future. It may help future patients by allowing better lab tests and research on why breast cancer starts, grows, and comes back.
This study collects tissue and/or blood samples from people with breast cancer to help future research. It may be useful if you’re already having surgery or another procedure as part of your treatment plan.
This study looks at proteins and imaging patterns (from tissue, fluid near the tumor, and blood) to better understand breast cancer markers. It may help researchers find clues that doctors can use to evaluate breast nodules and newly diagnosed invasive breast cancer.
This study is testing whether it is safe and practical to take multiple small tissue samples (biopsies) from different sites of your breast cancer over time. The goal is to learn how breast cancer changes as it grows, which could help doctors develop better treatments.
This study looks at breast cancer samples taken by biopsy to see how tissue “molecular markers” relate to how you respond to therapy and how the cancer behaves. It may help researchers better match future treatments to the biology of your tumor.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.